VER.H — Verisante Technology Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- CA$1.11m
- CA$1.48m
- CA$0.60m
Annual balance sheet for Verisante Technology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | — | 0.137 | 0.086 | 0.03 | 0.008 |
Net Total Receivables | 0.012 | 0.008 | 0.003 | 0.005 | 0.003 |
Prepaid Expenses | |||||
Total Current Assets | 0.012 | 0.146 | 0.088 | 0.036 | 0.012 |
Total Assets | 0.012 | 0.146 | 0.088 | 0.036 | 0.012 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.172 | 0.14 | 0.026 | 0.026 | 0.017 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.38 | 1.71 | 0.093 | 0.047 | 0.082 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.37 | -1.56 | -0.005 | -0.011 | -0.07 |
Total Liabilities & Shareholders' Equity | 0.012 | 0.146 | 0.088 | 0.036 | 0.012 |
Total Common Shares Outstanding |